Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report. | BMC Ophthalmol | 2023 | 37814274 | PubTator, text mining | PubMed |
| Development of a CD8+ T cell-based molecular classification for predicting prognosis and heterogeneity in triple-negative breast cancer by integrated analysis of single-cell and bulk RNA-sequencing. | Heliyon | 2023 | 37810147 | PubTator, text mining | PubMed |
| Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis. | Medicine (Baltimore) | 2023 | 37800814 | PubTator, text mining | PubMed |
| Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides. | Front Immunol | 2023 | 37790936 | PubTator, text mining | PubMed |
| Nature and nurture: understanding phenotypic variation in inborn errors of immunity. | Front Cell Infect Microbiol | 2023 | 37780853 | PubTator, text mining | PubMed |
| DGDTA: dynamic graph attention network for predicting drug-target binding affinity. | BMC Bioinformatics | 2023 | 37777712 | PubTator, text mining | PubMed |
| Identification of key genes in salivary gland in Sjögren's syndrome complicated with Hashimoto thyroiditis: Common pathogenesis and potential diagnostic markers. | Medicine (Baltimore) | 2023 | 37773833 | PubTator, text mining | PubMed |
| Malignant syphilis in HIV negative patient treated with ibrutinib. | Rev Esp Quimioter | 2023 | 37772340 | PubTator, text mining | PubMed |
| Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK. | Front Immunol | 2023 | 37771591 | PubTator, text mining | PubMed |
| A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas. | Int J Mol Sci | 2023 | 37762472 | PubTator, text mining | PubMed |
| Genomics of Treatable Traits in Asthma. | Genes (Basel) | 2023 | 37761964 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Infection in Cancer. | Cancers (Basel) | 2023 | 37760627 | PubTator, text mining | PubMed |
| Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy. | Cancers (Basel) | 2023 | 37760478 | PubTator, text mining | PubMed |
| The Role and Therapeutic Targeting of CCR5 in Breast Cancer. | Cells | 2023 | 37759462 | PubTator, text mining | PubMed |
| Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature. | Curr Oncol | 2023 | 37754514 | PubTator, text mining | PubMed |
| Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment. | Front Oncol | 2023 | 37746258 | PubTator, text mining | PubMed |
| Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications. | Front Cardiovasc Med | 2023 | 37745115 | PubTator, text mining | PubMed |
| Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly. | World J Gastroenterol | 2023 | 37744296 | PubTator, text mining | PubMed |
| Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition. | Sci Rep | 2023 | 37735204 | PubTator, text mining | PubMed |
| Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing. | Arthritis Res Ther | 2023 | 37730603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=11